NMPA Approval

Dexmedetomidine Hydrochloride and Sodium Chloride Injection

Approval Number

国药准字H20213035

Company江苏恒瑞医药股份有限公司

Registration Date

January 19, 2021

Drug Information

Generic Name

盐酸右美托咪定氯化钠注射液

Dosage Form

注射剂

Strength

50ml:200μg(按C13H16N2计)

Drug Type

化学药品

Registration Date

January 19, 2021

Company Information

Applicant Company

Company Name江苏恒瑞医药股份有限公司

Company Address

连云港经济技术开发区黄河路38号

Manufacturing Company

Company Name江苏恒瑞医药股份有限公司

Company Address

连云港经济技术开发区临港产业区东晋路

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

盐酸右美托咪定氯化钠注射液 - NMPA 批准文号 | MedPath